jamunjar-logo
whatsapp
cartmembermenu
Search for
"test & packages"
"physiotherapy"
"heart"
"lungs"
"diabetes"
"kidney"
"liver"
"cancer"
"thyroid"
"bones"
"fever"
"vitamin"
"iron"
"HTN"

Stone Analysis Kidney (Renal) calculus

Kidney
image

Report in 48Hrs

image

At Home

nofastingrequire

No Fasting Required

Details

Determine kidney stones chemical and crystalline composition

1,7502,250

22% OFF

Stone Analysis Kidney (Renal) Calculus - Comprehensive Medical Test Guide

  • Why is it done?
    • Test Purpose: Identifies the chemical composition and structure of kidney stones to determine the underlying cause of stone formation
    • Primary Indications:
    • Patients who have passed or had stones surgically removed and require chemical analysis for composition determination
    • Recurrent kidney stone formers requiring preventive treatment strategies based on stone type
    • Evaluation of unexplained renal colic or urinary obstruction to guide therapeutic interventions
    • Assessment of metabolic disorders causing abnormal stone formation
    • Typical Timing: Performed after spontaneous passage of stone, lithotripsy procedure, or surgical stone removal to allow proper laboratory analysis and treatment planning
  • Normal Range
    • Reference Ranges by Stone Composition:
    • Normal: Absence of kidney stone formation; no stone material present for analysis indicates normal urinary composition
    • Calcium Oxalate Stones: Most common (70-75% of all stones); composed primarily of calcium oxalate monohydrate or dihydrate crystalline structures
    • Magnesium Ammonium Phosphate (Struvite) Stones: 10-15% incidence; typically associated with urinary tract infections; composed of triple phosphate crystals
    • Uric Acid Stones: 5-10% occurrence; radiolucent on standard imaging; typically found in gout patients or those with high uric acid levels
    • Calcium Phosphate Stones: 5-8% incidence; associated with alkaline urine and renal tubular acidosis
    • Cystine Stones: <1% occurrence; associated with inherited cystinuria; characteristic hexagonal crystal appearance
    • Units of Measurement: Percentage composition by weight (%), qualitative identification of crystalline components, and morphological description of stone structure
    • Interpretation: Positive result indicates stone material present requiring identification of primary and secondary components; normal result indicates absence of calculi or insufficient specimen
  • Interpretation
    • Calcium Oxalate Stones Detected:
    • Indicates hypercalciuria, hyperoxaluria, or decreased citrate levels; requires evaluation for primary hyperparathyroidism, sarcoidosis, vitamin D toxicity, or dietary excess
    • Struvite Stones Identified:
    • Strongly associated with urease-producing bacterial infections (Proteus, Klebsiella); predisposition to staghorn calculi formation and potential renal damage if untreated
    • Uric Acid Stones Present:
    • Suggests gout, tumor lysis syndrome, excessive purine intake, chronic diarrhea, or acidic urine; responds well to urine alkalinization therapy
    • Calcium Phosphate Composition:
    • Associated with renal tubular acidosis, primary hyperparathyroidism, or distal renal tubular acidosis requiring specific therapeutic interventions and urine acidification
    • Cystine Stones Confirmation:
    • Diagnostic of inherited cystinuria; indicates abnormal amino acid transport requiring aggressive preventive measures including high urine output, urine alkalinization, and potentially chelating agents
    • Mixed Composition Stones:
    • Frequently observed with calcium oxalate and phosphate combinations; therapeutic approach targets the predominant component while addressing secondary factors
    • Factors Affecting Results:
    • Specimen quality and completeness; time delay between collection and analysis; contamination during collection process; incomplete stone material recovery
  • Associated Organs
    • Primary Organ Systems Involved:
    • Kidneys and urinary tract system; renal pelvis, ureters, and urethra for stone passage and obstruction complications
    • Bladder and prostate involvement in distal stone disease and urinary retention conditions
    • Associated Medical Conditions:
    • Nephrolithiasis (kidney stone disease) with various compositional etiologies requiring targeted prevention
    • Primary hyperparathyroidism causing hypercalcemia and stone formation
    • Gout and uric acid metabolism disorders associated with uric acid crystallization
    • Recurrent urinary tract infections particularly with urease-producing organisms causing struvite formation
    • Renal tubular acidosis causing calcium phosphate stone precipitation
    • Cystinuria - autosomal recessive genetic disorder affecting amino acid transport
    • Sarcoidosis with associated hypercalcemia and hypercalciuria
    • Inflammatory bowel disease causing hyperoxaluria and stone formation
    • Potential Complications and Associated Risks:
    • Urinary obstruction leading to acute renal failure and hydronephrosis with permanent renal damage if prolonged
    • Chronic kidney disease progression from recurrent stone formation and obstruction episodes
    • Urosepsis development secondary to infected obstructive stones requiring emergency intervention
    • Renal papillary necrosis from chronic stone disease and related urinary tract infections
  • Follow-up Tests
    • Recommended Subsequent Investigations:
    • 24-hour urine collection for measurement of calcium, oxalate, uric acid, citrate, phosphate, and magnesium levels to identify specific metabolic abnormalities
    • Serum calcium, phosphate, and parathyroid hormone (PTH) to evaluate for primary hyperparathyroidism
    • Serum uric acid and creatinine measurements to assess uric acid metabolism and renal function
    • Urine culture and urinalysis to identify urinary tract infections and assess urine pH for stone type correlation
    • Cystine-specific urine screening test in cases of cystine stone identification
    • Imaging Studies:
    • Non-contrast CT scan for detection of recurrent stone formation and assessment of kidney changes
    • Renal ultrasound or abdominal radiography for surveillance of stone recurrence and hydronephrosis development
    • Specialty Testing:
    • Parathyroid imaging and sestamibi scan if primary hyperparathyroidism suspected based on stone composition
    • Genetic counseling and DNA testing for cystinuria diagnosis confirmation and family screening
    • Monitoring Frequency:
    • Initial comprehensive metabolic workup within 4-6 weeks after stone passage or removal
    • Annual imaging surveillance for first-time stone formers with baseline metabolic risk factors
    • 6-12 month monitoring intervals for recurrent stone formers with targeted metabolic therapy
    • Repeat stone analysis if composition changes or recurrent stone formation occurs despite preventive measures
  • Fasting Required?
    • Fasting Requirement:
    • No - Fasting is NOT required for stone analysis itself, as this is direct examination of the physical specimen
    • Specimen Collection Requirements:
    • Obtain entire stone specimen that has passed spontaneously or been removed surgically with no contamination from urine or other substances
    • Allow stone to dry completely before placing in sterile container to prevent degradation or contamination
    • Do not wash stone with distilled water or other solutions that may alter composition or dissolve components
    • Special Instructions:
    • Preserve stone in dry sterile container at room temperature; avoid refrigeration or freezing which may cause crystal changes
    • Transport to laboratory promptly after collection, ideally within 24 hours to prevent decomposition
    • Maintain proper labeling with patient identification, collection date, and type of collection (passed vs. surgical removal)
    • If concurrent metabolic workup needed: Fast for 8-12 hours for serum calcium, PTH, and metabolic panel; 24-hour urine collection required on separate occasion with normal dietary intake
    • Medications to Avoid or Report:
    • No specific medication restrictions for stone analysis itself; however, report any medications affecting urine composition to laboratory
    • For accompanying metabolic studies: Inform physician of diuretics, thiazides, allopurinol, or uricosuric agents affecting test interpretation
    • Other Patient Preparation:
    • Educate patient on proper stone collection and storage to maximize specimen quality for accurate analysis
    • For surgical cases: Ensure urologist or surgical team collects stone before any fixative solutions applied
    • Coordinate timing with 24-hour urine collection for complete metabolic evaluation within appropriate test windows

How our test process works!

customers
customers